Protolabs (NYSE: PRLB) posted second-quarter earnings today that missed the consensus forecast on Wall Street, though the company beat on revenue.
The Maple Plain, Minn–based digital manufacturing outsourcer — which serves medtech and a host of other industries — reported profits of $12.9 million, or 47¢ per share, on sales of $123.0 million for the three months ended June 30, 2021, for a bottom-line gain of 2.4% and sales growth of 15.4% compared with Q2 2020.
Adjusted to exclude one-time items, earnings per share were 39¢, a nickel behind The Street, where analysts were looking EPS of 44¢ on sales of $122.2 million.
Get the full story on our sister site Medical Design & Outsourcing.